VNDA VANDA PHARMACEUTICALS INC
2026Q1 · CUSIP 921659108 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
169
Δ holders QoQ
+16
Breadth percentile
Top 19%
Whale holders
97
Δ whales
+12
Inst. holding value
$317M
New positions
49
Closed positions
33
Price momentum (1Q)
-1.9%
Put / Call
2/3
Breadth history (34 quarters)
Past Lit Events & Aftermath 3 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 19% | — | — |
| 2018Q4 | Top 9% | -26.0% | -23.9% |
| 2018Q3 | Top 7% | -16.1% | -33.8% |
Options Sentiment
Put holders
2
QoQ: -1
Call holders
3
QoQ: -4
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-4.06
EPS YoY
—
Revenue (TTM)
$0.2B
Revenue YoY
+8.2%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)